Educational Content Only: Not medical advice. Always consult a qualified healthcare provider before using any compounds. Many peptides are research chemicals not approved by the FDA.
Quick Summary
Triple agonist — the next generation of metabolic peptides
Also called: LY3437943
What is Retatrutide?
Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors simultaneously. Phase 2 clinical trials demonstrated extraordinary weight loss of approximately 24% of body weight at 48 weeks — the highest ever recorded for a pharmaceutical weight loss agent. Currently in Phase 3 trials and not yet approved for clinical use.
How It's Made
Retatrutide is a synthetic peptide developed by Eli Lilly that combines agonist activity at three distinct receptors: GLP-1, GIP, and glucagon. The glucagon receptor component adds additional metabolic benefits including increased energy expenditure.
Potential Benefits
Who Uses This?
Common goals and use cases for Retatrutide:
Where to Buy Retatrutide
Amino Club
Apex Peptides
Affiliate links — use code for discount. Always consult a healthcare provider before use.